Clinical Trials Directory

Trials / Completed

CompletedNCT05086354

Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer Survivors

Examining a Fast Movement Approach to Pediatric Therapy Intervention in Children and Adolescents That Have Completed Medical Treatment for Acute Lymphoblastic Leukemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with the peak incidences occurring in children two to five years of age. Children with ALL received neurotoxic chemotherapy agents for two to three years that causes decreased distal muscle strength and poor timing of muscle activation. After completion of medical treatment, ALL childhood cancer survivors (ALL CCS) are more likely to have an inactive lifestyle, resulting in life-long gross motor proficiency differences compared to their peers. ALL CCS typically do not utilize physical therapists' expertise after medical treatment has been completed. There are limited physical therapy (PT) intervention studies for ALL CCS.

Detailed description

We are performing a feasibility study to examine a movement based intervention that utilizes fast movements through jumping rope to improve balance, coordination, movement speed, and movement agility. The abilities to generate fast movements are required to perform functional activities and for playing sports. Participants will receive five in-person PT sessions and a home program for six weeks. The goal of this research is to determine the feasibility, acceptability, and promise of a PT program that emphasizes fast movements in ALL CCS.

Conditions

Interventions

TypeNameDescription
BEHAVIORALJUMPWarm-up, stretching, jumping rope, cool-down

Timeline

Start date
2018-03-16
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-10-20
Last updated
2022-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05086354. Inclusion in this directory is not an endorsement.